Efficacy of immune checkpoint inhibitors combined with chemotherapy for advanced gastric cancer
American Journal of Translational Research · 2026 · 18 (7) · 5704-5715
DOI: 10.62347/aocr6619 ↗At a glance
Journal article in American Journal of Translational Research, 2026. Written by Yueyun Hu and 3 co-authors. Institution: Department of Medical Oncology (I), Shijiazhuang People's Hospital Shijiazhuang 050081, Hebei, China. The full text is freely available in PubMed Central.
Topics: Onkologische Pflege
Abstract (original language)
Není k dispozici žádný abstrakt.
Subjects
Author keywords
Authors and institutions
- Department of Medical Oncology (I), Shijiazhuang People's Hospital Shijiazhuang 050081, Hebei, China.
- Department of Gastroenterology, Shijiazhuang People's Hospital Shijiazhuang 050081, Hebei, China.
- Department of Medical Oncology (II), Shijiazhuang People's Hospital Shijiazhuang 050081, Hebei, China.
Cite
APA
Hu, Y., Zhang, H., Shi, L., & Duan, Y. (2026). Efficacy of immune checkpoint inhibitors combined with chemotherapy for advanced gastric cancer. American Journal of Translational Research, 18(7), 5704-5715. https://doi.org/10.62347/aocr6619
Vancouver
Hu Y, Zhang H, Shi L, Duan Y. Efficacy of immune checkpoint inhibitors combined with chemotherapy for advanced gastric cancer. American Journal of Translational Research. 2026;18(7):5704-5715. doi:10.62347/aocr6619
BibTeX
@article{Hu2026,
author = {Hu, Yueyun and Zhang, Hongxin and Shi, Lin and Duan, Yuanyuan},
title = {Efficacy of immune checkpoint inhibitors combined with chemotherapy for advanced gastric cancer},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {7},
pages = {5704--5715},
doi = {10.62347/aocr6619}
}
EUVIMED